I

n the wake of shortages caused by Hurricane Maria, half a dozen groups that represent hospitals, doctors, and pharmacists are urging Congress to examine the lack of information provided by drug makers about product supplies.

The storm has caused shortages of various medicines — notably, solutions such as saline — but the extent to which manufacturing for many other drugs has been disrupted remains unclear. That’s because federal and state laws do not require companies to disclose which products are made at which plants.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.